Epidemiology, Diagnosis and Treatment of Adult Patients with Nosocomial Pneumonia - Update 2017 - S3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy, the German Radiological Society and the Society for Virology
© Georg Thieme Verlag KG Stuttgart · New York..
Nosocomial pneumonia (HAP) is a frequent complication of hospital care. Most data are available on ventilator-associated pneumonia. However, infections on general wards are increasing. A central issue are infections with multidrug resistant (MDR) pathogens which are difficult to treat in the empirical setting potentially leading to inappropriate use of antimicrobial therapy.This guideline update was compiled by an interdisciplinary group on the basis of a systematic literature review. Recommendations are made according to GRADE giving guidance for the diagnosis and treatment of HAP on the basis of quality of evidence and benefit/risk ratio.This guideline has two parts. First an update on epidemiology, spectrum of pathogens and antimicrobials is provided. In the second part recommendations for the management of diagnosis and treatment are given. New recommendations with respect to imaging, diagnosis of nosocomial viral pneumonia and prolonged infusion of antibacterial drugs have been added. The statements to risk factors for infections with MDR pathogens and recommendations for monotherapy vs combination therapy have been actualised. The importance of structured deescalation concepts and limitation of treatment duration is emphasized.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:72 |
|---|---|
| Enthalten in: |
Pneumologie (Stuttgart, Germany) - 72(2018), 1 vom: 17. Jan., Seite 15-63 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie – Update 2017 |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 01.04.2019 Date Revised 01.04.2019 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1055/s-0043-121734 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM280030819 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM280030819 | ||
| 003 | DE-627 | ||
| 005 | 20231225024413.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1055/s-0043-121734 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0933.xml |
| 035 | |a (DE-627)NLM280030819 | ||
| 035 | |a (NLM)29341032 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Dalhoff, K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Epidemiology, Diagnosis and Treatment of Adult Patients with Nosocomial Pneumonia - Update 2017 - S3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy, the German Radiological Society and the Society for Virology |
| 246 | 3 | 3 | |a Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie – Update 2017 |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.04.2019 | ||
| 500 | |a Date Revised 01.04.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Georg Thieme Verlag KG Stuttgart · New York. | ||
| 520 | |a Nosocomial pneumonia (HAP) is a frequent complication of hospital care. Most data are available on ventilator-associated pneumonia. However, infections on general wards are increasing. A central issue are infections with multidrug resistant (MDR) pathogens which are difficult to treat in the empirical setting potentially leading to inappropriate use of antimicrobial therapy.This guideline update was compiled by an interdisciplinary group on the basis of a systematic literature review. Recommendations are made according to GRADE giving guidance for the diagnosis and treatment of HAP on the basis of quality of evidence and benefit/risk ratio.This guideline has two parts. First an update on epidemiology, spectrum of pathogens and antimicrobials is provided. In the second part recommendations for the management of diagnosis and treatment are given. New recommendations with respect to imaging, diagnosis of nosocomial viral pneumonia and prolonged infusion of antibacterial drugs have been added. The statements to risk factors for infections with MDR pathogens and recommendations for monotherapy vs combination therapy have been actualised. The importance of structured deescalation concepts and limitation of treatment duration is emphasized | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Practice Guideline | |
| 700 | 1 | |a Abele-Horn, M |e verfasserin |4 aut | |
| 700 | 1 | |a Andreas, S |e verfasserin |4 aut | |
| 700 | 1 | |a Deja, M |e verfasserin |4 aut | |
| 700 | 1 | |a Ewig, S |e verfasserin |4 aut | |
| 700 | 1 | |a Gastmeier, P |e verfasserin |4 aut | |
| 700 | 1 | |a Gatermann, S |e verfasserin |4 aut | |
| 700 | 1 | |a Gerlach, H |e verfasserin |4 aut | |
| 700 | 1 | |a Grabein, B |e verfasserin |4 aut | |
| 700 | 1 | |a Heußel, C P |e verfasserin |4 aut | |
| 700 | 1 | |a Höffken, G |e verfasserin |4 aut | |
| 700 | 1 | |a Kolditz, M |e verfasserin |4 aut | |
| 700 | 1 | |a Kramme, E |e verfasserin |4 aut | |
| 700 | 1 | |a Kühl, H |e verfasserin |4 aut | |
| 700 | 1 | |a Lange, C |e verfasserin |4 aut | |
| 700 | 1 | |a Mayer, K |e verfasserin |4 aut | |
| 700 | 1 | |a Nachtigall, I |e verfasserin |4 aut | |
| 700 | 1 | |a Panning, M |e verfasserin |4 aut | |
| 700 | 1 | |a Pletz, M |e verfasserin |4 aut | |
| 700 | 1 | |a Rath, P-M |e verfasserin |4 aut | |
| 700 | 1 | |a Rohde, G |e verfasserin |4 aut | |
| 700 | 1 | |a Rosseau, S |e verfasserin |4 aut | |
| 700 | 1 | |a Schaaf, B |e verfasserin |4 aut | |
| 700 | 1 | |a Schreiter, D |e verfasserin |4 aut | |
| 700 | 1 | |a Schütte, H |e verfasserin |4 aut | |
| 700 | 1 | |a Seifert, H |e verfasserin |4 aut | |
| 700 | 1 | |a Spies, C |e verfasserin |4 aut | |
| 700 | 1 | |a Welte, T |e verfasserin |4 aut | |
| 700 | 0 | |a Unter Mitwirkung der folgenden Wissenschaftlichen Fachgesellschaften und Institutionen: Deutsche Gesellschaft für Chirurgie |e verfasserin |4 aut | |
| 700 | 0 | |a Deutsche Gesellschaft für Innere Medizin e. V. |e verfasserin |4 aut | |
| 700 | 0 | |a Deutsche Gesellschaft für Internistische Intensivmedizin und Notfallmedizin |e verfasserin |4 aut | |
| 700 | 0 | |a Deutsche Sepsis-Gesellschaft e. V. |e verfasserin |4 aut | |
| 700 | 0 | |a und Robert Koch-Institut |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pneumologie (Stuttgart, Germany) |d 1990 |g 72(2018), 1 vom: 17. Jan., Seite 15-63 |w (DE-627)NLM012597422 |x 1438-8790 |7 nnns |
| 773 | 1 | 8 | |g volume:72 |g year:2018 |g number:1 |g day:17 |g month:01 |g pages:15-63 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1055/s-0043-121734 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 72 |j 2018 |e 1 |b 17 |c 01 |h 15-63 | ||